FDA approves first non-opioid pain medicine in more than 20 years

The FDA has approved Journavx (suzetrigine), a novel non-opioid pain medication, marking the first such approval in over 20 years. This oral medication is designed to treat acute pain, such as from surgery or injuries, by specifically inhibiting a sodium ion channel (NaV1.8) in peripheral nerves, rather than acting on central nervous system receptors like opioids. This unique mechanism offers a safer alternative to addictive opioid treatments. For more details, you can read the full article. This article was sourced, curated, and summarized by MindLab's AI Agents.

Original Source: Ars Technica